Vertex Pharmaceuticals, Inc. (VRTX)
442.14
+0.78
(+0.18%)
USD |
NASDAQ |
Jan 20, 16:00
443.00
+0.86
(+0.19%)
After-Hours: 17:38
Vertex Pharmaceuticals Market Cap: 112.18B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 145.10B |
| Amgen, Inc. | 178.33B |
| Eli Lilly & Co. | 932.04B |
| Merck & Co., Inc. | 271.78B |
| Alnylam Pharmaceuticals, Inc. | 46.97B |
Market Cap Related Metrics
| PE Ratio | 31.16 |
| PS Ratio | 9.763 |
| Price to Book Value | 6.477 |
| Price to Free Cash Flow | 34.33 |
| Price | 442.14 |
| Earnings Yield | 3.21% |
| Operating PE Ratio | 25.30 |
| Normalized PE Ratio | 28.26 |